T-Stat is the first device to be labeled by the FDA as “sensitive to Ischemia” and has been proven in multiple trials as an easy-to-use and reliable tool for assessing the adequacy of oxygen delivery to tissue.
The T-Stat 303 provides a continuous, non-invasive and localized measurement, sensitive to regional and global ischemia. T-Stat reports a capillary-weighted oxygen saturation which is closely related to a local venous saturation measure (see "Contribution Of Capillary Venous And Arterial Blood for T-Stat˜).